Latest Quest Diagnostics Stories
As many as 19% of women received false negatives for cervical cancer when HPV-only tested, finds Quest Diagnostics Health Trends(TM) study published in Cancer Cytopathology of 256,648 women, one of
Company's HIT solutions turn health information into actionable insights to help ACOs, health systems, hospitals and physicians improve health care quality, outcomes and efficiencies MADISON,
MADISON, N.J., April 2, 2015 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic
AUSTIN, Texas, March 17, 2015 /PRNewswire/ -- Vermillion, Inc.
Proprietary Neurome(TM) service provides insight into the genetic causes of neurological disorders so parents and health care providers can develop personalized care strategies MADISON,
MADISON, N.J., Feb.
Agreement ensures continuing broad patient access to Quest's BRCAvantage(TM) services for evaluating genetic risk of developing breast, ovarian and other cancers MADISON, N.J., Feb.
Multi-year fee-based contract for Quest's test data and analytics expertise aims to reveal insights from national testing trends to promote guideline-based care and better outcomes for 4.4 million
MADISON, N.J., Jan.